COVID-19

Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1

Partial ORF1ab gene target failure in clinical SARS-CoV-2 testing identifies BA.2.12.1 variant samples

Development and performance of a point-of-care rapid antigen test for detection of SARS-CoV-2 variants

Unique construction of a point-of-care rapid antigen test using two pairs of monoclonal antibodies has led to good performance that remained durable across multiple variants in laboratory and clinical evaluations. Test should identify almost all individuals harboring infectious SARS-CoV-2.

Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19

Importance: Alterations to the saliva microbiome based on SARS-CoV-2 viral load indicate potential biologically relevant bacterial-viral relationships which may affect clinical outcomes in COVID-19 disease.

Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient

SARS-CoV-2 viral persistence in a solid organ transplant recipient

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York

We report the emergence of the SARS-CoV-2 variant lineage Iota (B.1.526) in New York City in early 2021

Pre-test symptom duration and cycle threshold values for SARS-CoV-2 reverse transcription-PCR (RT-PCR) predict COVID-19 mortality

SARS-CoV-2 RT-PCR Ct value and duration of symptoms may be useful in risk stratification of patients with COVID-19.

Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital

Increased CPE detection in patients with COVID-19 may signal a re-emergence of these highly resistant pathogens in the wake of the global pandemic. Increased surveillance and antimicrobial stewardship efforts will be needed to mitigate their future impact.